Forsta AP Fonden Has $12.35 Million Stock Position in Humana Inc. $HUM

Forsta AP Fonden boosted its holdings in shares of Humana Inc. (NYSE:HUM) by 84.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 48,200 shares of the insurance provider’s stock after buying an additional 22,100 shares during the period. Forsta AP Fonden’s holdings in Humana were worth $12,345,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently bought and sold shares of the company. Montag A & Associates Inc. raised its position in Humana by 1,880.0% during the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after buying an additional 94 shares during the period. CoreCap Advisors LLC raised its position in Humana by 54.4% during the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after buying an additional 37 shares during the period. Fideuram Asset Management Ireland dac acquired a new position in Humana during the fourth quarter valued at $27,000. Rosenberg Matthew Hamilton raised its position in Humana by 136.0% during the fourth quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock valued at $30,000 after buying an additional 68 shares during the period. Finally, Larson Financial Group LLC raised its position in Humana by 114.1% during the third quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock valued at $40,000 after buying an additional 81 shares during the period. 92.38% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts recently weighed in on the company. Evercore upped their price target on Humana from $195.00 to $250.00 in a research report on Thursday, April 30th. UBS Group upped their price target on Humana from $262.00 to $320.00 and gave the company a “neutral” rating in a research report on Friday, May 22nd. Wells Fargo & Company lowered Humana from a “cautious” rating to a “reduce” rating in a research report on Wednesday, May 20th. Leerink Partners upped their price target on Humana from $185.00 to $255.00 and gave the company a “market perform” rating in a research report on Thursday, April 30th. Finally, Seaport Research Partners lowered Humana to a “neutral” rating in a research report on Wednesday, May 20th. Nine research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and four have assigned a Sell rating to the stock. According to MarketBeat, Humana has an average rating of “Hold” and an average price target of $270.48.

Humana Stock Performance

Shares of NYSE HUM opened at $305.97 on Monday. The business’s 50-day moving average price is $231.96 and its two-hundred day moving average price is $228.98. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.77 and a quick ratio of 1.77. Humana Inc. has a one year low of $163.11 and a one year high of $315.66. The company has a market capitalization of $36.73 billion, a P/E ratio of 32.72, a price-to-earnings-growth ratio of 2.21 and a beta of 0.76.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 EPS for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. Humana had a return on equity of 10.45% and a net margin of 0.82%.The firm had revenue of $39.65 billion for the quarter, compared to the consensus estimate of $39.37 billion. During the same quarter in the previous year, the company posted $11.58 earnings per share. The business’s quarterly revenue was up 23.5% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000- EPS. Analysts anticipate that Humana Inc. will post 9.01 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a $0.885 dividend. The ex-dividend date is Friday, June 26th. This represents a $3.54 dividend on an annualized basis and a yield of 1.2%. Humana’s payout ratio is 37.86%.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.